Bayer healthcare head returns to Novartis as Chairman
FRANKFURT (Reuters) - Bayer AG said the head of its healthcare division, Joerg Reinhardt, is leaving to join his former employer Novartis as chairman.
Novartis earlier on Wednesday said its long-standing chairman and former Chief Executive would step down next month.
Reinhard will run for non-executive Chairman of the Board at Novartis' annual general meeting at the end of February and plans to take office on August 1. He will quit Bayer on February 28, the German group said on Wednesday.
Reinhard used to be Chief Operating Officer of Novartis.
Bayer's head of research and development Wolfgang Plischke will become interim head of Bayer HealthCare until a successor is appointed.
(Reporting by Ludwig Burger)
- Gaza fighting abates as diplomatic tension flares |
- Hague court orders Russia to pay $50 billion in Yukos case
- Pushing locals aside, Russians take top rebel posts in east Ukraine
- Europe subdued, Russia shares tumble on new sanctions
- Fighting complicates Ukraine crash probe, U.S., EU prepare Russia sanctions |
Robert Blendon of the Harvard School of Public Health says the Affordable Care Act's unpopularity in 12 key states will keep it a central issue in the 2014 elections. Video